CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,832,793
- in 7 filings, $10.2M under 10b5-1 plans
Net −$14,832,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −421 | $99.85 | $42K | 374,371 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −2,100 | $100.68 | $211K | 372,271 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −10,000 | $110.00 | $1.1M | 362,271 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −26,452 | 37,032 | ||
| 2026-08-27 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −5,000 | $85.02 | $425K | 397,271 |
| 2026-08-27 | Freidin Aaron Chief Financial Officer | Sale 10b5-1 | −7,900 | $85.01 | $672K | 253,083 |
| 2026-07-15 | CHASE WILLIAM J Director | Grant or award | +276 | $74.36 | $21K | 42,978 |
| 2026-07-15 | SUMME GREGORY L Director | Grant or award | +427 | $74.36 | $32K | 45,672 |
| 2026-07-15 | MIZELL STEVEN Director | Grant or award | +268 | $74.36 | $20K | 42,830 |
| 2026-06-18 | CHASE WILLIAM J Director | Grant or award | +5,491 | $63.74 | $350K | 42,702 |
| 2026-06-18 | MIZELL STEVEN Director | Grant or award | +5,491 | $63.74 | $350K | 42,562 |
| 2026-06-18 | SUMME GREGORY L Director | Grant or award | +5,491 | $63.74 | $350K | 45,245 |
| 2026-06-18 | Krevans Sarah Director | Grant or award | +5,491 | $63.74 | $350K | 42,628 |
| 2026-06-04 | Partridge Andrew John Chief Growth Officer | Sale | −1,491 | $61.08 | $91K | 163,738 |
| 2026-06-03 | Ofman Joshua J. Chief Executive Officer | Grant or award | +3,154 | $61.13 | $193K | 402,271 |
| 2026-06-01 | Ofman Joshua J. Chief Executive Officer | Grant or award | +27,901 | $64.40 | $1.8M | 399,117 |
| 2026-04-15 | MIZELL STEVEN Director | Grant or award | +396 | $49.79 | $20K | 37,071 |
| 2026-04-15 | CHASE WILLIAM J Director | Grant or award | +408 | $49.79 | $20K | 37,211 |
| 2026-04-15 | SUMME GREGORY L Director | Grant or award | +631 | $49.79 | $31K | 39,754 |
| 2026-04-08 | Freidin Aaron Chief Financial Officer | Sale | −45,806 | $49.92 | $2.3M | 260,669 |
Page 2 of 8 · 144 trades